[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@Generic_Tina](/creator/twitter/Generic_Tina)
"Eisai's Dayvigo approved in China. Daiichi Sankyo withdrew BLA in US. Samsung Bio secures CMO contracts. SK Bioscience expands vaccine manufacturing facility. CSPC is in outlicensing talks"  
![@Generic_Tina Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1511682976639119365.png) [@Generic_Tina](/creator/x/Generic_Tina) on [X](/post/tweet/1928973619079819639) 2025-06-01 00:35:24 UTC XX followers, XX engagements


"Hisamitsu's Q1FY26 revenue was down X% YoY due to subdued performance in Salonpas OTC products. However FY26 guidance was reiterated as Salonpas decline is seen as temporary"  
![@Generic_Tina Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1511682976639119365.png) [@Generic_Tina](/creator/x/Generic_Tina) on [X](/post/tweet/1944556271887388725) 2025-07-14 00:35:17 UTC XX followers, XX engagements


"Astellas sees XX% growth in Q1FY26 sales of Izervay in the U.S. In FY25 revenue from strategic brands improved XXX% YoY. Izervay Q1FY26 revenue enhances conviction on strategic brands"  
![@Generic_Tina Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1511682976639119365.png) [@Generic_Tina](/creator/x/Generic_Tina) on [X](/post/tweet/1944918652643631437) 2025-07-15 00:35:16 UTC XX followers, XX engagements


"Jiangsu Hengrui launches HK IPO. Wuxi Biologics to sell Germany plant. Chugai got Japan approval for gene therapy. Mayne Pharma was hit as FDA letter was made public"  
![@Generic_Tina Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1511682976639119365.png) [@Generic_Tina](/creator/x/Generic_Tina) on [X](/post/tweet/1923900195932340272) 2025-05-18 00:35:25 UTC XX followers, XXX engagements


"Nanjing Leads Biolabs launches HK$1.1B IPO to fund its ongoing and planned clinical development and regulatory affairs of pipeline assets. The company has fetched cornerstone investment of HK$ 542M"  
![@Generic_Tina Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1511682976639119365.png) [@Generic_Tina](/creator/x/Generic_Tina) on [X](/post/tweet/1946005806606139795) 2025-07-18 00:35:13 UTC XX followers, XX engagements


"Shanghai MicroPort MedBot expects 7080% revenue growth in 1H25 with net loss narrowing to RMB 125M. Toumai Laparoscopic Surgical Robot is driving growth with new orders and overseas installations"  
![@Generic_Tina Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1511682976639119365.png) [@Generic_Tina](/creator/x/Generic_Tina) on [X](/post/tweet/1947817789307142425) 2025-07-23 00:35:24 UTC XX followers, XX engagements


"Sino Biopharmaceutical is acquiring China-based clinical-stage biopharma company LaNova Medicines for $500M enhancing its oncology capabilities and global reputation in the pharmaceutical industry"  
![@Generic_Tina Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1511682976639119365.png) [@Generic_Tina](/creator/x/Generic_Tina) on [X](/post/tweet/1945643429184377311) 2025-07-17 00:35:16 UTC XX followers, XX engagements


"SK Bioscience initiates global Phase X trial of PCV21 vaccine. IDT Biologika shows revenue growth in 1Q25 on track to meet 2025 guidance. 1Q25 base business revenue increased XX% YoY"  
![@Generic_Tina Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1511682976639119365.png) [@Generic_Tina](/creator/x/Generic_Tina) on [X](/post/tweet/1937308506954301942) 2025-06-24 00:35:16 UTC XX followers, XX engagements


"3SBio signed $6B outlicensing deal with Pfizer for SSGJ-707 resulting in spectacular rally in 3SBio shares. Global trial initiation of SSGJ-707 and strong financial performance are expected ahead"  
![@Generic_Tina Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1511682976639119365.png) [@Generic_Tina](/creator/x/Generic_Tina) on [X](/post/tweet/1939845218901402107) 2025-07-01 00:35:15 UTC XX followers, XXX engagements


"Celltrion's 1Q25 results show a sequential decrease in revenue and operating profit but a sequential improvement in gross profit margin. The company reaffirmed its 2025 revenue guidance of KRW5T"  
![@Generic_Tina Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1511682976639119365.png) [@Generic_Tina](/creator/x/Generic_Tina) on [X](/post/tweet/1947174365701046723) 2025-07-21 05:58:40 UTC XX followers, XX engagements